The June 2026 intent
The June 2026 final guidance: FDA's intent to exempt certain unclassified devices — enforcement discretion, not deregulation.
Free field guide · PDF
The June 2026 intent, the eight categories, and the Class II wave — with the FDA practice you need.
Sourced from verified 2026 publications.
Enter your work email and we'll send the PDF straight to your inbox.
What's inside
Every figure in this guide traces to a named source — verified 2026 publications.
The June 2026 final guidance: FDA's intent to exempt certain unclassified devices — enforcement discretion, not deregulation.
The eight categories: ENT, gastro-urology, surgical, OB/GYN, physical medicine, neurological, toxicology.
The Class II wave: named product codes, the Cures Act engine, and the verify-before-you-skip rule.
This guide is market-access intelligence, not regulatory or legal advice. FDA exemption lists, enforcement policy, and classification practice change — professional review is required before business use.
Market Access Strategy Session
A Market Access Strategy Session maps your 510(k) route — exemption checks, classification, and submission strategy.
Professional review is required before business use.
Back to ghmap.io Questions? Talk to our team